Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s): CLAZF

Healthcare

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID viruses on contact. R-107 targets the Achilles heel of COVID, the spike protein on the surface of the virus. R-107 releases nitric oxide, which attaches to a specific amino acid on the spike protein, thereby disabling the spike protein. The CLA-1816 provides effective pain reduction, without the risks of addiction or respiratory suppression that exist with opioid analgesics. CLA-1816 strongly binds with and activates the alpha3 glycine pain receptor in the spine. The Company has leased a laboratory, office, and archival space in Beverly, Massachusetts.

TSXV:CLAS.H - Post by User

Claritas Pharmaceuticals Inc

<< Previous

Bullboard Posts

Next >>

Post by losingmyshirton Sep 07, 2021 4:17pm

211 Views

Post# 33820122

KALYTERA OR CLARITAS= DOOM AND GLOOM

.31 TODAY .

.29 TOMORROW

HEADING BACK TO .02

IF ONLY SOMEONE WOULD BELIEVE IN THIS COMPANY. THE PAST IS THE PAST. MAYBE BOB NEEDS A SECOND CHANCE. MAYBE HE DIDN'T HAVE HIS GAME FACE ON WHEN THEY PUMPED THIS AS GVHD WINNER. SURE THAT WAS A FIASCO AND YOU ALL LOST YOUR MONEY BUT MAYBE THINGS ARE DIFFERENT NOW.

OR MAYBE THINGS ARE THE SAME AS THEY ALWAYS WERE AND NO ONE MAKES MONEY ON THIS PLAY EXCEPT BOB AND HIS CRONIES.

<< Previous

Bullboard Posts

Next >>

Sirios Resource discovers visible gold in Quebec